Immunotherapy for osteosarcoma: Where do we go from here?

Journal Article (Journal Article;Review)

Osteosarcoma is the most common bone tumor in children and young adults, with few advances in survival and treatment, especially for metastatic disease, in the last 30 years. Recently, immunotherapy has begun to show promise in various adult cancers, but the utility of this approach for osteosarcoma remains relatively unexplored. In this review, we outline the mechanisms and status of immunotherapies currently in clinical trials as well as future therapies on the horizon, and discuss their potential application for osteosarcoma.

Full Text

Duke Authors

Cited Authors

  • Wedekind, MF; Wagner, LM; Cripe, TP

Published Date

  • September 2018

Published In

Volume / Issue

  • 65 / 9

Start / End Page

  • e27227 -

PubMed ID

  • 29923370

Electronic International Standard Serial Number (EISSN)

  • 1545-5017

Digital Object Identifier (DOI)

  • 10.1002/pbc.27227


  • eng

Conference Location

  • United States